CEO Joe Moscato of Generex Biotechnology Corp. (OTCQB: GNBT), returns to Stock Day to give an update on recent acquisitions, bringing products to market, and plans for growth in 2019.

OTCQB: GNBT # proprietary platform technology # RapidMist device # immunotherapeutic vaccines # allergic # and autoimmune diseases # Antigen Express # CD4+ T-helper stimulation # delivery of drugs # Ii protein # infectious # malignant # oral cavity # proprietary liquid formulations